Original Query: ALL
Previous Study | Return to List | Next Study

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01077154
Recruitment Status : Active, not recruiting
First Posted : February 26, 2010
Last Update Posted : November 30, 2017
Daiichi Sankyo, Inc.
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : August 31, 2017
  Estimated Study Completion Date : August 24, 2022